Publication
Title
Final results and outcomes by prior bevacizumab exposure, skin toxicity, and hypomagnesaemia from ASPECCT : randomized phase 3 non-inferiority study of panitumumab versus cetuximab in chemorefractory wild-type KRAS exon 2 metastatic colorectal cancer
Author
Abstract
Language
English
Source (journal)
European journal of cancer
Publication
2016
ISSN
0959-8049
1879-0852
Volume/pages
68(2016), p. 51-59
ISI
000387811600006
Full text (Publisher's DOI)
UAntwerpen
Faculty/Department
Research group
Publication type
Subject
Affiliation
Publications with a UAntwerp address
External links
Web of Science
Record
Identification
Creation 10.01.2017
Last edited 23.11.2018
To cite this reference